Put companies on watchlist
Travelex Issuerco 2 Plc
ISIN: XS2248458049
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Travelex Issuerco 2 Plc · ISIN: XS2248458049 · EQS - Company News (52 News)
Country: Great Britain · Primary market: Great Britain · EQS NID: 1325547
11 April 2022 04:50PM

Travelex Issuerco 2 Plc: Completion of £35 million funding raise


EQS-News: Travelex Issuerco 2 Plc / Key word(s): Miscellaneous

11.04.2022 / 16:50
The issuer is solely responsible for the content of this announcement.


Travelex Issuerco 2 Plc

Completion of £35 million funding raise
Travelex Issuerco 2 Plc
11 April 2022

Travelex Issuerco 2 Plc ("Travelex" or the "Company")

11 April 2022

Travelex announces completion of £35 million funding raise

Following the announcement made by Travelex on 25 March 2022, Travelex is pleased to announce that it has successfully concluded the raising of £35 million of additional funding following the issuance of an additional number of new money notes (in a face value amount of approximately £37 million) by the Company (the "Additional New Money Notes") and the connected issuance of ordinary shares in Travelex Topco Limited, which are stapled to the Additional New Money Notes.

The Additional New Money Notes have the same terms and conditions and ISIN (XS2248458049) as the existing new money notes. An application will shortly be made for the Additional New Money Notes to be admitted to trading on the Vienna MTF (as operated by the Vienna Stock Exchange) and an announcement will be made once such admission has occurred.

Enquiries:

Travelex
For investor related queries:
Victoria.Benis-Lonsdale@travelex.com
Lan.Tang@travelex.com

For other enquiries:
Press@travelex.com

-END-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



11.04.2022 This Corporate News was distributed by EQS Group AG. www.eqs.com


Language: English
Company: Travelex Issuerco 2 Plc
8 Sackville Street
W1S 3DG London
United Kingdom
Phone: +44(0)7584336458
E-mail: Victoria.benis-lonsdale@travelex.com
Internet: https://www.travelex-corporate.com/
ISIN: XS2248458049, XS2248456936
WKN: A284QJ
Listed: Vienna Stock Exchange
EQS News ID: 1325547

 
End of News EQS News Service

1325547  11.04.2022 

fncls.ssp?fn=show_t_gif&application_id=1325547&application_name=news&site_id=boersengefluester_html

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.